Works matching DE "BIOSIMILARS"

Results: 926

Biosimilars and immunogenicity: a matter of concern?

Published in:

Expert Opinion on Drug Safety, 2025, v. 24, n. 5, p. 519, doi. 10.1080/14740338.2025.2467817

By:

Jarab, Anan S.;
Abu Heshmeh, Shrouq R.;
Al Meslamani, Ahmad Z.

Publication type:

Article

Efficacy, safety, and cost-effectiveness of biosimilars of bevacizumab in näive patients with diabetic macular edema.

Published in:

Indian Journal of Pharmacology, 2024, v. 56, n. 4, p. 248, doi. 10.4103/ijp.ijp_58_24

By:

Virani, Shalini;
Bhatiwal, Akshay;
Rewri, Parveen

Publication type:

Article

Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilars.

Published in:

Rheumatology Advances in Practice, 2022, v. 6, n. 3, p. 1, doi. 10.1093/rap/rkac099

By:

Quinlivan, Alannah;
Lester, Susan;
Barrett, Claire;
Whittle, Samuel;
Rowett, Debra;
Black, Rachel;
Chand, Vibhasha;
Marine, Franca;
March, Lyn;
Sinnathurai, Premarani;
Buchbinder, Rachelle;
Hill, Catherine

Publication type:

Article

Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator.

Published in:

2022

By:

Valor-Méndez, Larissa;
Dorn, Carla;
Manger, Bernhard;
Schett, Georg;
Kleyer, Arnd

Publication type:

Letter to the Editor

Trastuzumab biosimilars vs trastuzumab originator in the treatment of HER2-positive breast cancer: a systematic review and network meta-analysis.

Published in:

Immunopharmacology & Immunotoxicology, 2022, v. 44, n. 6, p. 809, doi. 10.1080/08923973.2022.2090956

By:

Liu, Tong;
Liu, Duo;
Jin, Yao;
Dong, Mei

Publication type:

Article

Analyzing Biosimilars in Brazil: Comprehensive Specifications of the Regulatory System.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2023, v. 57, p. S499, doi. 10.5530/ijper.57.3s.57

By:

Deeksha, Kethareshwara Sujatha;
Veeranna, Balamuralidhara;
Ravindra, Gowthami Kodlahalli

Publication type:

Article

Comparability Pathway for the Approval of Similar Biologics with Respect to Reference Biologics in Europe and Brazil.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2020, v. 54, p. S19, doi. 10.5530/ijper.54.2s.58

By:

Nori, Lakshmi Prasanthi;
Ravi, Prasuna

Publication type:

Article

INVESTIGATING THE PHYSICOCHEMICAL, NON-CLINICAL, AND CLINICAL CRITERIA FOR ASSESSING COMPARABILITY IN RANIBIZUMAB BIOSIMILARS: A COMPREHENSIVE REVIEW.

Published in:

Farmacia, 2024, v. 72, n. 3, p. 488, doi. 10.31925/farmacia.2024.3.2

By:

ALMAAYTAH, AMMAR

Publication type:

Article

A PHARMACEUTICAL GUIDE TO ADALIMUMAB BIOSIMILARS.

Published in:

Farmacia, 2022, v. 70, n. 3, p. 379, doi. 10.31925/farmacia.2022.3.1

By:

ALMAAYTAH, AMMAR

Publication type:

Article

Future of anti-VEGF: biosimilars and biobetters.

Published in:

International Journal of Retina & Vitreous, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40942-021-00343-3

By:

Kapur, Monika;
Nirula, Suvansh;
Naik, Mayuresh P.

Publication type:

Article

Biosimilars: To switch or not to switch - that is the question.

Published in:

Rheumatology / Reumatologia, 2020, v. 58, n. 1, p. 1, doi. 10.5114/reum.2020.93111

By:

Szekanecz, Zoltán

Publication type:

Article

Biosimilar switching - current state of knowledge.

Published in:

Rheumatology / Reumatologia, 2018, v. 56, n. 4, p. 234, doi. 10.5114/reum.2018.77975

By:

Wiland, Piotr;
Batko, Bogdan;
Brzosko, Marek;
Kucharz, Eugeniusz J.;
Samborski, Włodzimierz;
Świerkot, Jerzy;
Więsik-Szewczyk, Ewa;
Feldman, Julia

Publication type:

Article

Biosimilar biological drugs in the treatment of inflammatory bowel diseases.

Published in:

Gastroenterology Review / Przegląd Gastroenterologiczny, 2019, v. 14, n. 4, p. 223, doi. 10.5114/pg.2019.90093

By:

Kaniewska, Magdalena;
Eder, Piotr;
Gąsiorowska, Anita;
Gonciarz, Maciej;
Kierkuś, Jarosław;
Małecka-Panas, Ewa;
Rydzewska, Grażyna

Publication type:

Article

Examining the Impact of the World Health Organization 2022 Guidelines on Evaluation of Biosimilars for Non-Local Comparators in Biosimilar Studies on Middle East and North Africa Member States.

Published in:

Pharmacy, 2024, v. 12, n. 3, p. 94, doi. 10.3390/pharmacy12030094

By:

Strand, Michael W.;
Watanabe, Jonathan H.

Publication type:

Article

A Comprehensive Review of Evidence and Challenges in Switching from Originator Drugs to Biosimilars of Monoclonal Antibodies: Focus on Rituximab and Trastuzumab.

Published in:

Journal of Drug Delivery & Therapeutics, 2025, v. 15, n. 2, p. 149, doi. 10.22270/jddt.v15i2.7012

By:

Sathyan, Arya;
Mohanapriya M.;
Madhanraja R.;
Indu Vadana K. S.;
Indhuja K.;
Sumathi P.;
Varshini G.

Publication type:

Article

Similarity assessment by multivariate statistics method based on the distance between biosimilar and originator.

Published in:

Bioresources & Bioprocessing, 2021, v. 8, n. 1, p. 1, doi. 10.1186/s40643-021-00378-2

By:

Xu, Jian;
Shao, Zhihui;
Han, Xiaoxiong;
Huang, Yingfeng;
Zou, Xun;
Shen, Yaling

Publication type:

Article

ISPAD Clinical Practice Consensus Guidelines 2022: Insulin treatment in children and adolescents with diabetes.

Published in:

Pediatric Diabetes, 2022, v. 23, n. 8, p. 1277, doi. 10.1111/pedi.13442

By:

Cengiz, Eda;
Danne, Thomas;
Ahmad, Tariq;
Ayyavoo, Ahila;
Beran, David;
Ehtisham, Sarah;
Fairchild, Jan;
Jarosz‐Chobot, Przemyslawa;
Ng, Sze May;
Paterson, Megan;
Codner, Ethel

Publication type:

Article

Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40222-5

By:

de Oliveira Ascef, Bruna;
Almeida, Matheus Oliveira;
de Medeiros-Ribeiro, Ana Cristina;
de Oliveira Andrade, Danieli Castro;
de Oliveira Junior, Haliton Alves;
de Soárez, Patrícia Coelho

Publication type:

Article

Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40222-5

By:

de Oliveira Ascef, Bruna;
Almeida, Matheus Oliveira;
de Medeiros-Ribeiro, Ana Cristina;
de Oliveira Andrade, Danieli Castro;
de Oliveira Junior, Haliton Alves;
de Soárez, Patrícia Coelho

Publication type:

Article

Efficacy, safety, and immunogenicity of biosimilars compared with the biologic etanercept in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Published in:

Systematic Reviews, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s13643-024-02715-w

By:

Andrade, Aurélio Matos;
da Motta Girardi, Juliana;
da Silva, Erica Tatiane;
Barbosa, Jakeline Ribeiro;
Pereira, Daniella Cristina Rodrigues

Publication type:

Article

Generic orphan drug substitution: a critical analysis of global practices and Saudi Arabia's perspective.

Published in:

Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1376009

By:

Alakeel, Yousif S.;
Rampakakis, Emmanouil;
AlRumaih, Ali;
AlRuwaisan, Rana;
Abushal, Maha;
AlDalaan, Abdullah M.;
Idrees, Majdy M.;
Alanazi, Zaid D.;
AlKoait, Hanouf;
Muaadi, Abdulrahman;
AlAfra, Majed Ali M.;
AlShaya, Shaya A.;
AlHomida, Suliman

Publication type:

Article

Factors influencing bioequivalence evaluation of insulin biosimilars based on a structural equation model.

Published in:

Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1143928

By:

Huarui Shao;
Yi Tao;
Chengyong Tang

Publication type:

Article

Panel: Biosimilar Adoption Dependent on Various Stakeholder Economics.

Published in:: Journal of Oncology Navigation & Survivorship, 2022, v. 13, n. 1, p. 9
Publication type:: Article

Update on Oncology Biosimilars in 2020.

Published in:: Journal of Oncology Navigation & Survivorship, 2020, v. 11, n. 8, p. 283
Publication type:: Article

Bilanz 2020: Roche.

Published in:

Nachrichten aus der Chemie, 2021, v. 69, n. 4, p. 43, doi. 10.1002/nadc.20214107008

By:

Bulmahn, Maren

Publication type:

Article

Bilanz Novartis.

Published in:

Nachrichten aus der Chemie, 2020, v. 68, n. 5, p. 45, doi. 10.1002/nadc.20204096407

By:

Bulmahn, Maren

Publication type:

Article

Clinical outcomes of switching to adalimumab biosimilar (MSB11022) in patients with rheumatoid arthritis: RESTART Spanish Registry.

Published in:

Current Medical Research & Opinion, 2024, v. 40, n. 8, p. 1431, doi. 10.1080/03007995.2024.2372295

By:

García-Miguel, Javier;
Yankova Komsalova, Liliya;
Mata Arnaiz, Cristina;
Alegre-Sancho, Juan José;
González Polo, Javier;
Torrente-Segarra, Vicenç;
Tornero Molina, Jesús;
Navarro Angeles, Vanessa Andrea;
Caramés, Cristina;
Cristóbal, Ion

Publication type:

Article

ADA_ETA_BIO2021: real-world evaluation of adherence, persistence, and cost-effectiveness of originator and biosimilar biologic drugs in the treatment of rheumatoid arthritis: a multicenter study in Italy.

Published in:

Current Medical Research & Opinion, 2023, v. 39, n. 12, p. 1729, doi. 10.1080/03007995.2023.2287600

By:

Santoleri, Fiorenzo;
Lasala, Ruggero;
Abrate, Paolo;
Pestrin, Laura;
Pasut, Enrico;
Modesti, Germana;
Musicco, Felice;
Fulgenzio, Chiara;
Zuzolo, Eva;
Pieri, Gabriella;
Roperti, Martina;
Gazzola, Pietro;
Gambera, Marco;
Martignoni, Isabella;
Montresor, Valentina;
De Vita, Francesco;
Guarino, Francesca;
Grossi, Laura;
Di Fabio, Letizia;
Roberti, Cristina

Publication type:

Article

Cost per responder of biologic drugs used in the treatment of moderate-to-severe plaque psoriasis in France and Germany.

Published in:

Current Medical Research & Opinion, 2023, v. 39, n. 6, p. 833, doi. 10.1080/03007995.2023.2214046

By:

Nyholm, Nanna;
Schnack, Henrik;
Danø, Anne;
Skowron, François

Publication type:

Article

The Importance of Real-World Data in Evaluating the Safety of Biosimilars: A Descriptive Study of Clinical Practice in an Oncohematological Italian Population.

Published in:

Cancers, 2024, v. 16, n. 19, p. 3419, doi. 10.3390/cancers16193419

By:

Urru, Silvana A. M.;
Mayer, Flavia;
Spila Alegiani, Stefania;
Paoloni, Francesca;
Guella, Anna;
Murru, Roberta;
Bucaneve, Giampaolo;
Formoso, Giulio;
Racanelli, Vito;
Ferrarini, Isacco;
Fozza, Claudio;
Longo, Giuseppe;
Musicco, Felice;
Campomori, Annalisa

Publication type:

Article

Define Critical Parameters of Trastuzumab-Mediated ADCC Assays via Assay Optimization Processes, Focusing on the Impact of Cryopreserved Effector Cells on Assay Performance.

Published in:

Cancers, 2024, v. 16, n. 13, p. 2367, doi. 10.3390/cancers16132367

By:

Peng, Hanjing;
Endo, Yukinori;
Wu, Wen Jin

Publication type:

Article

New Era of Immune-Based Therapy in Intrahepatic Cholangiocarcinoma.

Published in:

Cancers, 2023, v. 15, n. 15, p. 3993, doi. 10.3390/cancers15153993

By:

Kawamura, Etsushi;
Matsubara, Tsutomu;
Kawada, Norifumi

Publication type:

Article

Comparative Safety Profiles of Oncology Biosimilars vs. Originators in Europe: An Analysis of the EudraVigilance Database.

Published in:

Cancers, 2023, v. 15, n. 14, p. 3680, doi. 10.3390/cancers15143680

By:

Nikitina, Victoria;
Santi Laurini, Greta;
Montanaro, Nicola;
Motola, Domenico

Publication type:

Article

Real-World Use of Granulocyte-Colony Stimulating Factor in Patients with Breast Cancer from Alberta, Canada.

Published in:

Cancers, 2022, v. 14, n. 24, p. 6197, doi. 10.3390/cancers14246197

By:

Ding, Philip Q.;
Newcomer, Brandt J.;
Cheung, Winson Y.

Publication type:

Article

Reduction of biologic pricing following biosimilar introduction: Analysis across 57 countries and regions, 2012–19.

Published in:

PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0304851

By:

Chen, Hui-Han;
Yemeke, Tatenda;
Ozawa, Sachiko

Publication type:

Article

Imbalanced machine learning classification models for removal biosimilar drugs and increased activity in patients with rheumatic diseases.

Published in:

PLoS ONE, 2023, v. 18, n. 11, p. 1, doi. 10.1371/journal.pone.0291891

By:

Castro Corredor, David;
Calvo Pascual, Luis Ángel

Publication type:

Article

Safety outcomes when switching between biosimilars and reference biologics: A systematic review and meta-analysis.

Published in:

PLoS ONE, 2023, v. 18, n. 10, p. 1, doi. 10.1371/journal.pone.0292231

By:

Herndon, Thomas M.;
Ausin, Cristina;
Brahme, Nina N.;
Schrieber, Sarah J.;
Luo, Michelle;
Andrada, Frances C.;
Kim, Carol;
Sun, Wanjie;
Zhou, Lingjie;
Grosser, Stella;
Yim, Sarah;
Ricci, M. Stacey

Publication type:

Article

Efficacy, Safety and Immunogenicity of Subcutaneous Infliximab (CT-P13 SC) Monotherapy vs Combination Therapy With Immunosuppressants -- Post Hoc Analysis of LIBERTY-CD and LIBERTY-UC Studies.

Published in:

Gastroenterology & Hepatology, 2024, v. 20, p. 3

By:

Lichtenstein, Gary R.

Publication type:

Article

Diagnosing and Treating Noncardiac Chest Pain.

Published in:

Gastroenterology & Hepatology, 2024, v. 20, n. 9, p. 511

By:

Lichtenstein, Gary R.

Publication type:

Article

Exploring the Use of Biosimilars to Treat Patients With Inflammatory Bowel Disease.

Published in:

Gastroenterology & Hepatology, 2024, v. 20, n. 7, p. 367

By:

Lichtenstein, Gary R.

Publication type:

Article

Clinical Guide to Navigating the Landscape of Biosimilars for Inflammatory Bowel Disease.

Published in:

Gastroenterology & Hepatology, 2024, v. 20, n. 7, p. 376

By:

Bhat, Shubha;
Kane, Sunanda V.

Publication type:

Article

Safety and efficacy comparisons of intravenous trastuzumab biosimilars to the reference product medicine in treatment‐naïve and switch‐over patients with breast cancer: a systematic and meta‐analysis.

Published in:

Journal of Pharmacy Practice & Research, 2024, v. 54, n. 1, p. 1, doi. 10.1002/jppr.1882

By:

Song, Nina K.;
Musa, Hala;
Soriano, Michael;
Batger, Mellissa;
Hawkins, Bryson;
Ramzan, Iqbal;
Hibbs, David E.;
Ong, Jennifer

Publication type:

Article

Comparison of Two Treatment Strategies in Inflammatory Bowel Disease: Biosimilar Adalimumab Monotherapy or in Combination with Azathioprine.

Published in:

Iranian Journal of Gastroenterology & Hepatology (GOVARESH), 2023, v. 27, n. 4, p. 220

By:

Moghbel, Niloufar;
Deihim, Tina;
Aletaha, Najmeh;
Drayani, Naser Ebrahimi;
Shayegan, Neda;
Pishgar, Elham;
Anjidani, Nassim;
Alborzi, Foroogh

Publication type:

Article

Efficacy, immunogenicity and cost analysis of a systematic switch from originator infliximab to biosimilar CT-P13 of all patients with inflammatory arthritis from a single center.

Published in:

Acta Reumatológica Portuguesa, 2019, v. 44, n. 4, p. 303

By:

Valido A.;
Silva-Dinis J.;
Saavedra M. J.;
Iria I.;
Gonçalves J.;
Lopes J. P.;
Fonseca J. E.

Publication type:

Article

Monitoring the transition of patients on biologics in rheumatoid arthritis: Consensus guidance for pharmacists.

Published in:

Pharmacy Practice (1886-3655), 2021, v. 19, n. 3, p. 1, doi. 10.18549/PharmPract.2021.3.2377

By:

CHOQUETTE, Denis;
CHAN, Jonathan;
BARDI, Mohammad;
WHISKIN, Carolyn;
TORANI, Gabriel;
SMITH, Brennan K.;
SIHOTA, Aaron

Publication type:

Article

Biosimilars and implications for pharmacy practice: Ready or not, here they come!

Published in:

Pharmacy Practice (1886-3655), 2019, v. 17, n. 3, p. 1, doi. 10.18549/PharmPract.2019.3.1659

By:

HOBBS, Andrea L.;
CRAWFORD, Joshua P.

Publication type:

Article

A Time-response Measure to Assess Clinical Equivalence in Rheumatoid Arthritis: an Assessment Using Data From Clinical Trials of Biosimilars.

Published in:

Statistics in Biopharmaceutical Research, 2022, v. 14, n. 2, p. 204, doi. 10.1080/19466315.2020.1832567

By:

O'Kelly, Michael;
Zhang, Aijing;
Lipkovich, Ilya;
Song, Guochen;
Reeve, Russell;
Ratitch, Bohdana;
Li, Siying;
Behnke, Martha;
Kay, Jonathan;
Chow, Shein-Chung;
Baek, Inyoung

Publication type:

Article

Type I Error Inflation of Blinded Sample Size Re-Estimation in Equivalence Testing.

Published in:

Statistics in Biopharmaceutical Research, 2021, v. 13, n. 2, p. 156, doi. 10.1080/19466315.2020.1845232

By:

Glimm, Ekkehard;
Yau, Lillian;
Woehling, Heike

Publication type:

Article

Testing Procedures for Claiming Success on at Least k Out of m Hypotheses with an Application to Biosimilar Development.

Published in:

Statistics in Biopharmaceutical Research, 2021, v. 13, n. 1, p. 106, doi. 10.1080/19466315.2020.1730233

By:

Mielke, Johanna;
Jones, Byron;
Posch, Martin;
König, Franz

Publication type:

Article

Statistical Assessment of Biosimilarity Based on the Relative Distance Between Follow-on Biologics for Time-to-Event Endpoints.

Published in:

Statistics in Biopharmaceutical Research, 2021, v. 13, n. 1, p. 91, doi. 10.1080/19466315.2020.1721317

By:

Lee, Taehee;
Kang, Seung-Ho

Publication type:

Article